Cargando…
Biomarkers Reflecting The Destruction Of The Blood-Brain Barrier Are Valuable In Predicting The Risk Of Lymphomas With Central Nervous System Involvement
OBJECTIVE: We aimed to identify the biomarkers in cerebrospinal fluid (CSF) that facilitate the diagnosis of lymphomas with central nervous system (CNS) involvement. METHODS: Four cases of non-Hodgkin’s lymphoma (NHL) patients with/without CNS involvement were enrolled respectively, and non-CNS tumo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857655/ https://www.ncbi.nlm.nih.gov/pubmed/31807026 http://dx.doi.org/10.2147/OTT.S222432 |
_version_ | 1783470807314333696 |
---|---|
author | Yu, Wenjun Si, Mengya Li, Li He, Ping Fan, Zhiqiang Zhang, Qiaoxin Jiao, Xiaoyang |
author_facet | Yu, Wenjun Si, Mengya Li, Li He, Ping Fan, Zhiqiang Zhang, Qiaoxin Jiao, Xiaoyang |
author_sort | Yu, Wenjun |
collection | PubMed |
description | OBJECTIVE: We aimed to identify the biomarkers in cerebrospinal fluid (CSF) that facilitate the diagnosis of lymphomas with central nervous system (CNS) involvement. METHODS: Four cases of non-Hodgkin’s lymphoma (NHL) patients with/without CNS involvement were enrolled respectively, and non-CNS tumor patients (n=3) were selected to be the controls. Lab biomarkers, cytokines, and tight junction proteins (TJs) in CSF and serum were measured. RESULTS: When comparing the CNS to non-CNS group, cytokine including MMP-9 (15.24 vs 0.36 ng/mL), CCL-2 (1922.04 vs 490.68 pg/mL), and sVCAM-1 (61.36 vs 9.00 pg/mL), TJs including OCLN (6.68 vs 2.59 pg/mL), and ZO-1 (710.04 vs 182.98 pg/mL) in CSF were significantly higher in lymphomas patients with CNS involvement than those without CNS involvement. However, serum biomarkers were not significantly elevated. Contrary to the major findings, all conventional biomarkers and MRI results showed no significant change. CONCLUSION: CSF biomarkers affecting BBB disruption are valuable in mirroring the risk of lymphoma CNS metastasis. Further study with a larger sample size is needed to verify these biomarkers in predicting lymphoma CNS involvement. |
format | Online Article Text |
id | pubmed-6857655 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-68576552019-12-05 Biomarkers Reflecting The Destruction Of The Blood-Brain Barrier Are Valuable In Predicting The Risk Of Lymphomas With Central Nervous System Involvement Yu, Wenjun Si, Mengya Li, Li He, Ping Fan, Zhiqiang Zhang, Qiaoxin Jiao, Xiaoyang Onco Targets Ther Original Research OBJECTIVE: We aimed to identify the biomarkers in cerebrospinal fluid (CSF) that facilitate the diagnosis of lymphomas with central nervous system (CNS) involvement. METHODS: Four cases of non-Hodgkin’s lymphoma (NHL) patients with/without CNS involvement were enrolled respectively, and non-CNS tumor patients (n=3) were selected to be the controls. Lab biomarkers, cytokines, and tight junction proteins (TJs) in CSF and serum were measured. RESULTS: When comparing the CNS to non-CNS group, cytokine including MMP-9 (15.24 vs 0.36 ng/mL), CCL-2 (1922.04 vs 490.68 pg/mL), and sVCAM-1 (61.36 vs 9.00 pg/mL), TJs including OCLN (6.68 vs 2.59 pg/mL), and ZO-1 (710.04 vs 182.98 pg/mL) in CSF were significantly higher in lymphomas patients with CNS involvement than those without CNS involvement. However, serum biomarkers were not significantly elevated. Contrary to the major findings, all conventional biomarkers and MRI results showed no significant change. CONCLUSION: CSF biomarkers affecting BBB disruption are valuable in mirroring the risk of lymphoma CNS metastasis. Further study with a larger sample size is needed to verify these biomarkers in predicting lymphoma CNS involvement. Dove 2019-11-11 /pmc/articles/PMC6857655/ /pubmed/31807026 http://dx.doi.org/10.2147/OTT.S222432 Text en © 2019 Yu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Yu, Wenjun Si, Mengya Li, Li He, Ping Fan, Zhiqiang Zhang, Qiaoxin Jiao, Xiaoyang Biomarkers Reflecting The Destruction Of The Blood-Brain Barrier Are Valuable In Predicting The Risk Of Lymphomas With Central Nervous System Involvement |
title | Biomarkers Reflecting The Destruction Of The Blood-Brain Barrier Are Valuable In Predicting The Risk Of Lymphomas With Central Nervous System Involvement |
title_full | Biomarkers Reflecting The Destruction Of The Blood-Brain Barrier Are Valuable In Predicting The Risk Of Lymphomas With Central Nervous System Involvement |
title_fullStr | Biomarkers Reflecting The Destruction Of The Blood-Brain Barrier Are Valuable In Predicting The Risk Of Lymphomas With Central Nervous System Involvement |
title_full_unstemmed | Biomarkers Reflecting The Destruction Of The Blood-Brain Barrier Are Valuable In Predicting The Risk Of Lymphomas With Central Nervous System Involvement |
title_short | Biomarkers Reflecting The Destruction Of The Blood-Brain Barrier Are Valuable In Predicting The Risk Of Lymphomas With Central Nervous System Involvement |
title_sort | biomarkers reflecting the destruction of the blood-brain barrier are valuable in predicting the risk of lymphomas with central nervous system involvement |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857655/ https://www.ncbi.nlm.nih.gov/pubmed/31807026 http://dx.doi.org/10.2147/OTT.S222432 |
work_keys_str_mv | AT yuwenjun biomarkersreflectingthedestructionofthebloodbrainbarrierarevaluableinpredictingtheriskoflymphomaswithcentralnervoussysteminvolvement AT simengya biomarkersreflectingthedestructionofthebloodbrainbarrierarevaluableinpredictingtheriskoflymphomaswithcentralnervoussysteminvolvement AT lili biomarkersreflectingthedestructionofthebloodbrainbarrierarevaluableinpredictingtheriskoflymphomaswithcentralnervoussysteminvolvement AT heping biomarkersreflectingthedestructionofthebloodbrainbarrierarevaluableinpredictingtheriskoflymphomaswithcentralnervoussysteminvolvement AT fanzhiqiang biomarkersreflectingthedestructionofthebloodbrainbarrierarevaluableinpredictingtheriskoflymphomaswithcentralnervoussysteminvolvement AT zhangqiaoxin biomarkersreflectingthedestructionofthebloodbrainbarrierarevaluableinpredictingtheriskoflymphomaswithcentralnervoussysteminvolvement AT jiaoxiaoyang biomarkersreflectingthedestructionofthebloodbrainbarrierarevaluableinpredictingtheriskoflymphomaswithcentralnervoussysteminvolvement |